Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases
February 6, 2024
electroCore Expands Intellectual Property Portfolio
ROCKAWAY, N.J. , Feb. 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to systems and methods for treating disorders associated
January 9, 2024
electroCore Expands Intellectual Property Portfolio
ROCKAWAY, N.J. , Jan. 09, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to systems and methods for treating post-traumatic stress
December 26, 2023
electroCore Expands Intellectual Property Portfolio
electroCore Granted Two New U.S. Patents ROCKAWAY, N.J. , Dec. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark

Investor Contact

Investor Relations

973.302.9253
Investors@electrocore.com